---
title: 'Value-Based Indication-Specific Pricing and Weighted-Average Pricing: Estimated
  Price and Cost Savings for Cancer Drugs'
date: '2024-12-31'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39739243/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250101170753&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: Value-based indication-specific and weighted-average pricing
  could help to align the value and price of new indications, thereby reducing expenditure
  on drugs with multiple ...'
disable_comments: true
---
CONCLUSIONS: Value-based indication-specific and weighted-average pricing could help to align the value and price of new indications, thereby reducing expenditure on drugs with multiple ...